Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-12

Clinical Trial Update: GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis [Phase 3]

View source ↗

Summary

Phase 3 trial of glycocholic acid for inborn errors of bile acid synthesis completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • glycocholic acid (glycocholic acid)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Bile Acid Synthesis Defect, Inborn Error of Bile Acid Metabolism | Phase 3 | Status: COMPLETED | Results posted: 2022-05-12